UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading

Journal of translational medicine, 2023-03, Vol.21 (1), p.222-222, Article 222

2023

Link zum Volltext

Verfügbarkeit prüfen

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Arthritis research & therapy, 2021-07, Vol.23 (1), p.1-204, Article 204

2021

Link zum Volltext

Verfügbarkeit prüfen

Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis

Journal of dermatological science, 2016-07, Vol.83 (1), p.52-59

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia

Blood cancer journal (New York), 2023-12, Vol.13 (1), p.188-188, Article 188

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)

The Prostate, 2012-06, Vol.72 (8), p.913-924

2012

Link zum Volltext

Verfügbarkeit prüfen

Common interactions between S100A4 and S100A9 defined by a novel chemical probe

PloS one, 2013-05, Vol.8 (5), p.e63012

2013

Link zum Volltext

Verfügbarkeit prüfen

Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment

Journal for immunotherapy of cancer, 2015-12, Vol.3 (1), p.53-53, Article 53

2015

Link zum Volltext

Verfügbarkeit prüfen

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Journal for immunotherapy of cancer, 2023-01, Vol.11 (1), p.e005319

2023

Link zum Volltext

Verfügbarkeit prüfen

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse

PloS one, 2018-05, Vol.13 (5), p.e0196598-e0196598

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting S100A9 in the Inflammatory Myelodysplastic Hematopoietic Niche Reprograms the Functional Properties of CD271+ Mesenchymal Stromal Cells

Blood, 2022-11, Vol.140 (Supplement 1), p.4028-4029

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2712: Naptumomab Estafenatox induces T cell recognition, turning anti-PD-1 unresponsive "cold" tumors into "hot" responsive tumors

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2712-2712

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Inflammatory Niche in MDS By Tasquinimod Restores Hematopoietic Support and Suppresses Immune-Checkpoint Expression in Vitro

Blood, 2021-11, Vol.138 (Supplement 1), p.2596-2596

2021

Link zum Volltext

Verfügbarkeit prüfen

Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo

Blood, 2021-11, Vol.138 (Supplement 1), p.1594-1594

2021

Link zum Volltext

Verfügbarkeit prüfen

Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma model

Journal of immunotherapy (1997), 2012-05, Vol.35 (4), p.344

2012

Link zum Volltext

Verfügbarkeit prüfen

S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes

Cancer research communications, 2023-03, Vol.3 (3), p.420-430

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract B17: Immunomodulation by tasquinimod: Combination with immunotherapy results in enhanced CD8 T cell responses and improved antitumor effects

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (1_Supplement), p.B17-B17

2013

Link zum Volltext

Verfügbarkeit prüfen

An N -(alkylcarbonyl)anthranilic acid derivative prolongs cardiac allograft survival synergistically with cyclosporine A in a high-responder rat model

Transplant immunology, 2010-08, Vol.23 (4), p.180-184

2010

Link zum Volltext

Verfügbarkeit prüfen

Paquinimod prevents development of diabetes in the non-obese diabetic

PloS one, 2018-05, Vol.13 (5), p.e0196598

2018

Link zum Volltext

Verfügbarkeit prüfen

Growth of the postnatal rat retina in vitro: quantitative RT-PCR analyses of mRNA expression for photoreceptor proteins

Molecular vision, 2003-12, Vol.9 (79), p.657-664

2003

Link zum Volltext

Verfügbarkeit prüfen

Abstract B78: Immunomodulation by tasquinimod: Skewing of tumor infiltrating myeloid cell populations

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (1_Supplement), p.B78-B78

2013

Link zum Volltext

Verfügbarkeit prüfen

Development of glutamate receptor subunit 2 immunoreactivity in postnatal rat retina

Visual neuroscience, 2000-09, Vol.17 (5), p.737-742

2000

Link zum Volltext

Verfügbarkeit prüfen

Developmental expression of DCC in the rat retina

Brain research. Developmental brain research, 2001-09, Vol.130 (1), p.133-138

2001

Link zum Volltext

Verfügbarkeit prüfen

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Nature communications, 2017-11, Vol.8 (1), p.1738-1738, Article 1738

2017

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Nature communications, 2020-04, Vol.11 (1), p.1714-1714, Article 1714

2020

Link zum Volltext

Verfügbarkeit prüfen

Ekospel

Books Abroad, 1958, Vol.32 (2), p.213-214

Thompson, Lawrence S.

1958

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)
Reviews
(1)

Sprache

Englisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(14)
Animals
(11)
Humans
(11)
Medical And Health Sciences
(11)
Medicin Och Hälsovetenskap
(11)
Clinical Medicine
(8)
Klinisk Medicin
(8)
Immunology
(7)
Mice
(7)
Oncology
(7)
Basic Medicine
(5)
Cell Line, Tumor
(5)
Female
(5)
Immunotherapy
(5)
Medicinska Och Farmaceutiska Grundvetenskaper
(5)
Tumors
(5)
Cancer
(4)
Care And Treatment
(4)
Gene Expression
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia

Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)

Common interactions between S100A4 and S100A9 defined by a novel chemical probe

Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse

Targeting S100A9 in the Inflammatory Myelodysplastic Hematopoietic Niche Reprograms the Functional Properties of CD271+ Mesenchymal Stromal Cells

Abstract 2712: Naptumomab Estafenatox induces T cell recognition, turning anti-PD-1 unresponsive "cold" tumors into "hot" responsive tumors

Targeting the Inflammatory Niche in MDS By Tasquinimod Restores Hematopoietic Support and Suppresses Immune-Checkpoint Expression in Vitro

Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo

Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma model

S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes

Abstract B17: Immunomodulation by tasquinimod: Combination with immunotherapy results in enhanced CD8 T cell responses and improved antitumor effects

An N -(alkylcarbonyl)anthranilic acid derivative prolongs cardiac allograft survival synergistically with cyclosporine A in a high-responder rat model

Paquinimod prevents development of diabetes in the non-obese diabetic

Growth of the postnatal rat retina in vitro: quantitative RT-PCR analyses of mRNA expression for photoreceptor proteins

Abstract B78: Immunomodulation by tasquinimod: Skewing of tumor infiltrating myeloid cell populations

Development of glutamate receptor subunit 2 immunoreactivity in postnatal rat retina

Developmental expression of DCC in the rat retina

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Ekospel

Suchergebnisse filtern